stock logo
AARTIDRUGS
₹477.45
+0.10 (0.02%)

Aarti Drugs Ltd. (AARTIDRUGS) live share price today at NSE / BSE

Overview
Charts
Results
News & Events

Expert Verdict for Aarti Drugs Ltd. (AARTIDRUGS) Share

View details
Today`s low
0.00
Today`s high
0.00
Today`s return
Aarti Drugs Ltd. (AARTIDRUGS) Share Price Today
Performance Of Aarti Drugs Ltd. (AARTIDRUGS) Share Today
Opening Price:477.80
Previous closing Price:477.35
Volume of Aarti Drugs Ltd. (AARTIDRUGS) share:1,09,808
Value of Share:477.45
Fundamental of Aarti Drugs Ltd. (AARTIDRUGS) Share Price
Market Capitalisation:4,360 Cr.
P/E Ratio:25.93
P/B Ratio:3.19
Sector P/E:45.65
EPS (TTM):18.42
Dividend Yield:0.21
14D - RSI:58.29
50 DMA:453.76
200 DMA:432.85

Note: The above data is mentioned as per the Aarti Drugs Ltd. (AARTIDRUGS) share price today.

Aarti Drugs Ltd. (AARTIDRUGS) Share Price Today At NSE

    • Live Aarti Drugs Ltd. (AARTIDRUGS) Share Price NSE India: ₹477.45
    • Previous Closing Price: ₹477.35
    • Open Price: ₹477.80
    • High: ₹481.50
    • Low: ₹470.10

Aarti Drugs Ltd. (AARTIDRUGS) Share Price Today At BSE

  • Live Aarti Drugs Ltd. (AARTIDRUGS) Share Price BSE India: ₹476.05
  • Previous Closing Price: ₹477.75
  • Open Price: ₹479.00
  • High: ₹481.90
  • Low: ₹470.80

Historical Price Of Aarti Drugs Ltd. (AARTIDRUGS) Share

The table below shows the variations in Aarti Drugs Ltd. (AARTIDRUGS) share price from January 2018 to July 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
January 2018156.24161.50196.25155.7513,41,337-3.26
February 2018150.10155.31170.00136.391,68,580-3.36
March 2018126.50151.40152.75124.252,26,096-16.45
April 2018143.43129.99152.49126.761,96,04410.34
May 2018129.91143.89146.75129.251,23,312-9.71
June 2018138.51130.04166.25127.5010,03,7616.52
July 2018139.86138.50145.50122.683,26,5180.98
August 2018138.74139.86147.49135.005,17,376-0.8
September 2018137.31139.85171.00133.8810,10,152-1.81
October 2018147.86140.00152.35134.003,56,9305.62
November 2018138.24148.74154.75118.755,72,462-7.06
December 2018144.16137.90145.59137.382,44,1024.54
January 2019147.24144.16162.15140.763,42,1752.13
February 2019147.35147.40152.25137.832,40,801-0.03
March 2019159.33147.50176.75145.3311,31,7058.02
April 2019155.06159.33161.33153.381,74,072-2.68
May 2019142.30154.13155.50138.502,06,821-7.67
June 2019132.68142.74152.09127.081,73,288-7.05
July 2019115.56131.75133.65114.001,77,727-12.29
August 2019116.36114.76134.86106.754,33,1291.39
September 2019113.46116.28122.21108.504,58,223-2.42
October 2019134.49114.90138.95108.052,74,61217.05
November 2019130.00135.00136.25125.552,05,623-3.7
December 2019144.83129.50156.23123.263,86,37811.83
January 2020153.63144.83162.23139.166,56,2766.08
February 2020173.24153.00202.99144.2116,63,24613.23
March 2020125.58175.50182.25105.257,57,953-28.45
April 2020178.80127.00191.68125.0011,23,33740.79
May 2020243.06176.00248.75173.0043,93,52838.1
June 2020317.64244.00325.85227.7839,61,92630.18
July 2020435.06317.99451.25310.0028,77,13136.82
August 2020678.04442.75929.75425.251,47,83,68453.14
September 2020771.30662.64772.25650.0058,49,70716.4
October 2020680.95809.851,026.95615.652,43,35,031-15.92
November 2020715.05678.40738.40619.551,62,22,9125.4
December 2020705.15715.00811.00645.651,51,42,689-1.38
January 2021673.40710.00756.00670.001,12,11,025-5.15
February 2021630.90674.00695.00628.0056,60,826-6.39
March 2021694.30634.00786.00630.902,52,51,3569.51
April 2021709.95698.00747.95671.051,10,15,4071.71
May 2021727.35706.10841.80706.102,46,51,1733.01
June 2021707.50730.00778.50704.0586,99,522-3.08
July 2021667.40709.65749.75662.7574,01,390-5.95
August 2021616.15670.00687.80580.0045,52,416-8.04
September 2021607.30617.95648.30605.0035,06,334-1.72
October 2021585.55610.00645.60573.1551,17,727-4.01
November 2021506.75590.00599.70484.0039,05,797-14.11
December 2021544.90511.75608.00504.9550,05,5006.48
January 2022503.45550.00552.30485.0027,71,501-8.46
February 2022455.70505.65536.40450.0026,54,503-9.88
March 2022429.10450.00471.40419.0034,46,900-4.64
April 2022461.20430.00531.40430.0038,63,3007.26
May 2022425.55460.00460.00401.1016,54,048-7.49
June 2022403.85435.00452.00378.0010,54,163-7.16
July 2022418.90400.50455.65394.1017,17,8954.59
August 2022431.50426.30489.95414.4552,12,0411.22
September 2022468.75427.00488.60426.0552,77,0059.78
October 2022479.30462.00512.40441.8526,97,8793.74
November 2022452.90481.70488.00440.5012,82,992-5.98
December 2022460.10452.10474.75440.8516,99,0791.77
January 2023401.00462.95464.00391.0514,28,185-13.38
February 2023366.30410.00429.45356.8522,51,038-10.66
March 2023337.75367.00404.70313.903,23,68,439-7.97
April 2023420.85339.00436.00336.001,76,18,08824.14
May 2023436.80431.00478.00422.851,10,41,1871.35
June 2023465.10440.00493.00439.1071,15,9235.7
July 2023594.60467.75645.75456.553,69,20,46627.12
November 2023487.70468.00500.90457.9548,51,0424.21
December 2023489.20490.30526.45470.9594,16,884-0.22
January 2024526.65492.00545.00488.0088,20,7657.04
February 2024497.60530.00568.00495.0051,08,640-6.11
March 2024434.30498.20511.90431.0536,62,300-12.83
April 2024504.55436.50519.15436.5037,48,32815.59
May 2024476.90504.55508.95456.0036,69,098-5.48
June 2024504.55488.80538.95451.0530,21,6403.22
July 2024510.30505.00563.20500.0045,26,2241.05
August 2024582.80509.40635.00492.051,42,68,07014.41
September 2024513.20585.00591.00505.0543,69,743-12.27
October 2024484.15513.00529.00466.1028,65,036-5.62
November 2024460.80484.15502.00439.3020,23,407-4.82
December 2024460.40464.95497.60419.5553,12,721-0.98
January 2025405.40462.55476.750.0027,87,153-12.36
February 2025351.35405.60433.00350.0028,11,052-13.38
March 2025340.30353.05377.50330.0542,05,553-3.61
April 2025349.00340.00373.65312.0033,43,5192.65
May 2025443.85349.85497.00341.251,98,16,39726.87
June 2025458.15446.40494.00431.0052,60,5662.63
July 2025477.35459.95498.70456.6535,84,5403.78

Shareholding Pattern of Aarti Drugs Ltd. (AARTIDRUGS) Shares In Stock Market

The below depicted shareholding pattern is as per the Aarti Drugs Ltd. (AARTIDRUGS) Industries Ltd. Share Price Market of March 2025.

Promoters55.48%
Foreign Institutions2.25%
Retail and Others33.44%
Other Domestic Institutions0.08%
Mutual Funds8.75%
Aarti Drugs Ltd. (AARTIDRUGS) Share Background
Face Value10.00
ISININE767A01016
Market Lot1.00
InstrumentEQUITY
Should you invest in Aarti Drugs Ltd. (AARTIDRUGS) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Aarti Drugs Ltd. (AARTIDRUGS) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Aarti Drugs Ltd. (AARTIDRUGS) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 4,360 Cr.
  • Aartidrugs FAQs

    Is Aarti Drugs Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Aarti Drugs Ltd. is in Buy zone for Short term and is in Hold zone for Long term.

    Should I buy Aarti Drugs Ltd. share now?

    arrow

    As per our verdict, Aarti Drugs Ltd. is in the Buy zone for Short term.

    Should I buy Aarti Drugs Ltd. shares for the long term?

    arrow

    As per our verdict, Aarti Drugs Ltd. is in Hold zone for Long term.

    What is Aarti Drugs Ltd. share price today?

    arrow

    The Aarti Drugs Ltd. share price today is 477.45.

    How to buy Aarti Drugs Ltd. share?

    arrow

    You can buy Aarti Drugs Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Aarti Drugs Ltd.?

    arrow

    The share price of Aarti Drugs Ltd. is 477.45, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Aarti Drugs Ltd.?

    arrow

    PE ratio of Aarti Drugs Ltd. is 25.93 and PB ratio of Aarti Drugs Ltd. is 3.19.

    How’s PE of Aarti Drugs Ltd. compared to its sector?

    arrow

    PE ratio of Aarti Drugs Ltd. is 25.93 whereas the sector PE ratio is 45.65.

    What is the market cap of Aarti Drugs Ltd.?

    arrow

    Aarti Drugs Ltd.’s market cap is 4360.

    What are today’s High and Low prices of Aarti Drugs Ltd. ?

    arrow

    Today’s High of Aarti Drugs Ltd. is 481.5.
    Today’s Low of Aarti Drugs Ltd. is 470.1.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    General
    arrow down